Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
712
datasets available to search
ShareScore release 0.9.0
Dataset results
712 results for “mantle”
A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia Wi
ClinicalTrials.gov study NCT03190330. IPD Sharing: Not stated. Countries: 1. Publications: 0.
17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00117988. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00022945. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular
ClinicalTrials.gov study NCT01381692. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHL
ClinicalTrials.gov study NCT00151320. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Clinical Trial of Ublituximab and Umbralisib With CHOP (U2-CHOP) Followed by U2 Maintenance (U2-CHOP-U2) in Previously Untreated Mantle Cell Lymphoma (MCL)
ClinicalTrials.gov study NCT04692155. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ofatumumab and Bortezomib in Subjects With Relapsed CD20+Diffuse Large B Cell, Follicular, or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT01397591. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03623373. IPD Sharing: NO. Countries: 1. Publications: 0.
Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00711828. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma
ClinicalTrials.gov study NCT05025423. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ixazomib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04047797. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor
ClinicalTrials.gov study NCT03235544. IPD Sharing: YES. Countries: 11. Publications: 0.
Zevalin and Velcade in Relapsed/Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT01497275. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT05431179. IPD Sharing: UNDECIDED. Countries: 0. Publications: 1.
A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00843050. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Acalabrutinib Study in Indian Patients With Chronic Lymphocytic Leukaemia & Relapsed and Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04930536. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of MabThera (Rituximab) Addition to Regularly Prescribed Chemotherapy in Patients With Untreated Mantle Cell Lymphoma.
ClinicalTrials.gov study NCT01144403. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituximab in Patients With Mantle Cell Lymphoma
ClinicalTrials.gov study NCT07285590. IPD Sharing: YES. Countries: 2. Publications: 0.
S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00376961. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of RAD001 in Participants With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy
ClinicalTrials.gov study NCT00702052. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.